The directors present their report for the consolidated entity consisting of Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) and the entities it controlled at the end of, or during, the year ended 31 December 2017. Throughout the report, the consolidated entity is referred to as the Group.
Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) is pleased to announce that it has been awarded another contract to deliver its smart-packaged MABR technology solution, for a 1,000 m3/day wastewater treatment plant for the local government of Zhenfeng County, Guizhou province, China.
Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) is pleased to announce that it has delivered US$8 million in new contract wins calendar year-to-date including the three NIROBOX(TM) orders announced on 1 March 2018. The new contracts were across the Company's growing global footprint, and further strengthened Fluence's market position in designated industries and geographies.
Cardia Bioplastics Limited (ASX:CNN) (OTCMKTS:CDRBY) is pleased to announce that Australian Stellar Films and Cardia Bioplastics have partnered to produce environmentally friendly, high quality and cost competitive Biohybrid(TM) films tailored for the global personal care and hygiene products industry.
Cardia Bioplastics Limited (ASX:CNN) is pleased to announce that it has been awarded the IAIR Green Excellence Award. IAIR Awards is one of the world's leading ranking and prize for excellence in global economy and sustainability.
Cardia Bioplastics Limited (ASX:CNN) is pleased to announce that it has developed proprietary Biohybrid(TM) packaging films tailored to the innovative bag-in-bag water packaging process.
Cardia Bioplastics Limited (ASX:CNN) is pleased to announce that it has secured patent protection for its Cardia Compostable resin family of products from the United States Patent and Trademark Office.
